Pioneering research from Uniogen at ESCMID Global 2025:

We are excited to announce our participation in ESCMID Global 2025 in Vienna, where our scientists will present their groundbreaking research in C. difficile and B. pertussis diagnostics. This event brings together leading experts in clinical microbiology and infectious diseases, and we are proud to contribute to the conversation shaping the future of our industry.

Meet our presenters:

Presenting two posters at the event, Teppo Salminen and Krista Korpi will showcase their work on developing highly sensitive lateral flow assays for C. difficile and B. pertussis. Both assays utilize Uniogen’s Upcon^TM upconverting nanoparticle labelling technology and show great performance. If you’re attending ESCMID Global 2025, be sure to visit our posters and connect with our team:

Sunday 13.4.2025 12:00 – 13:30
Session title: 02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging, treatment & prevention)
Poster: P0911 Automated lateral flow immunoassay based on upconverting nanoparticles for serological point-of-care diagnosis of pertussis

Tuesday 15.4.2025 12:00 – 13:30
Session title: 08. Healthcare-associated infections, infection prevention & control
Poster: P3272 Lateral flow immunoassay based on upconverting nanoparticles for the diagnosis of Clostridioides difficile toxins

 

Follow us on LinkedIn for more insights from the event!